GlassScriptPhysician profile
Alexandra R Davies
NPI 1841241148
$1,182.34
in general payments reported to CMS, 2019-2025
17 companies · $318 in 2025
The $318 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $104 · 2022: $162 · 2023: $300 · 2024: $298 · 2025: $318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $838 · Education: $78.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $837.56 |
| Education | $78.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $357.90 | 2022-2024 | Rybelsus, Ozempic, Wegovy |
| Glaxosmithkline, LLC. | $128.26 | 2023-2025 | Arexvy, Trelegy Ellipta, Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.99 | 2025 | Ofev |
| Edwards Lifesciences Corporation | $103.68 | 2021 | |
| Sanofi-Aventis U.S. LLC | $78.99 | 2025 | |
| Lilly USA, LLC | $68.33 | 2022-2024 | Mounjaro, Zepbound, Jardiance |
| Shield Therapeutics INC | $64.26 | 2023-2024 | Accrufer |
| Astrazeneca Pharmaceuticals LP | $49.16 | 2024 | Airsupra, Farxiga |
| Madrigal Pharmaceuticals | $38.54 | 2024 | Resmetirom |
| Baxter Healthcare | $24.26 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Grifols USA, LLC | $23.77 | 2025 | Prolastin-C Liquid |
| Dexcom, INC. | $22.96 | 2023 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $21.75 | 2024 | Gardasil 9, Vaxelis, Gardasil |
| Ferring Pharmaceuticals INC. | $21.73 | 2023 | Rebyota |
| Regeneron Healthcare Solutions, INC. | $21.24 | 2025 | Dupixent |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $17.64 | 2025 | Arikayce |
| E.R. Squibb & Sons, L.L.C. | $14.88 | 2024 | Eliquis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandra Davies listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.